(4) AACR Annual Meeting 2019
March 29 – April 3, 2019
Georgia World Congress Center
Atlanta, GA
The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.
Anchor Molecular will be presenting a poster, “Comparison of Five Commercial Kits on Extraction of cfDNA from Human Plasma Containing Defined Amount of Genomic DNA Contamination: The Usage of DNA-Depleted Plasma as a Control Matrix for Monitoring ctDNA Assay”. Presentation information pertaining to this poster is below:
Session Category: Clinical Research
Session Title: Circulating and Cell-free Biomarkers for Diagnosis and Monitoring of Cancer 2
Session Date and Time: Monday Apr 1, 2019 8:00 AM – 12:00 PM
Location: Georgia World Congress Center, Exhibit Hall B, Poster Section 18
Poster Board Number: 24
Permanent Abstract Number: 1355
Also, Anchor Molecular team will be on booth #1947 in the Exhibit Hall to discuss more about our new products and services. If you’re attending the conference and wish to arrange an on-site meeting with our team, please email us at info@anchormolecular.com.
(3) Molecular Medicine TRI-CON 2019
March 10 – March 15, 2019
Moscone South Convention Center
San Francisco, CA
The 26th International Molecular Medicine Tri-Conference 2019 will be discussing themes of cancer research, big data, molecular diagnostics, precision medicine, rare diseases, data science, human microbiome, point-of-care diagnostics, infectious diseases, and so much more.
Anchor Molecular will be presenting a poster, “Characterization of DNA-Depleted Plasma and Evaluation of Plasma-Based Quality Control for Monitoring the DNA Extraction” in the Exhibit Hall. Our R&D team will be available to answer your questions and discuss a collaboration opportunity to study the effect of plasma on cfDNA/ctDNA detection.
Also, Anchor Molecular team will be on the booth #636 in the Exhibit Hall to discuss more about our products and services. If you’re attending the conference and wish to arrange an on-site meeting with our team, please email us at info@anchormolecular.com.
The overview and highlight of a poster presented by Dr. Yabin Lu, a co-founder of Anchor Molecular, are recorded. “Want to remove the doubt and be confident in your results? Fix your extraction FIRST!” A video clip is found here.
(2) 6th Annual Advances in Prenatal Molecular Diagnostics 2018
October 29 – October 30, 2018
Hyatt Regency Cambridge
Cambridge, MA
This event examines the scientific advances in tools and technologies as well as clinical implementation for next generation prenatal diagnostics.
Anchor Molecular presents a poster, “Characterization of DNA-free Plasma and Its Usage as True Plasma-Based Quality Control Standards for ctDNA Testing”.
(1) Liquid Biopsy Summit 2018
June 20 – June 22, 2018
Hotel Kabuki
San Francisco, CA
The continued development of “noninvasive” methods to detect and monitor disease has led to an unprecedented time in biomolecular medicine. At the Liquid Biopsy Summit, experts present and consider process and technology refinements that can enable molecular liquid biopsies to become a fulcrum in the future of precision medicine.
Anchor Molecular presents a poster, “Characterization of DNA-free Plasma and Its Usage as True Plasma-Based Quality Control Standards for ctDNA Testing”.
